Metformin: From mechanisms of action to therapies

Cell Metabolism

Volumn 20, Issue 6, 2014, Pages 953-966

  Foretz, Marc ^a,b,c   Guigas, Bruno ^d   Bertrand, Luc ^e   Pollak, Michael ^f   Viollet, Benoit ^a,b,c  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; ANTIDIABETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANTINEOPLASTIC ACTIVITY; ATHEROGENESIS; CARDIOVASCULAR SYSTEM; DIABETIC CARDIOMYOPATHY; DRUG MECHANISM; GLUCONEOGENESIS; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; LIPID METABOLISM; LIVER METABOLISM; META ANALYSIS (TOPIC); METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHARMACOEPIDEMIOLOGY; PHARMACOGENOMICS; PHASE 1 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANIMAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; ENERGY METABOLISM; METABOLISM;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; OXIDATIVE PHOSPHORYLATION;

EID: 84919615360     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2014.09.018     Document Type: Review

References (122)

1. C. Algire, L. Amrein, M. Bazile, S. David, M. Zakikhani, and M. Pollak Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo Oncogene 30 2011 1174 1182
2. American Diabetes Association Standards of medical care in diabetes - 2014 Diabetes Care 37 Suppl 1 2014 S14 S80
3. S. Andrzejewski, S.P. Gravel, M. Pollak, and J. St-Pierre Metformin directly acts on mitochondria to alter cellular bioenergetics Cancer Metab. 2 2014 10.1186/2049-3002-2-12 Published online August 28, 2014
4. J. Bai, N. Zhang, Y. Hua, B. Wang, L. Ling, A. Ferro, and B. Xu Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts PLoS ONE 8 2013 e72120
5. M. Balteau, N. Tajeddine, C. de Meester, A. Ginion, C. Des Rosiers, N.R. Brady, C. Sommereyns, S. Horman, J.L. Vanoverschelde, and P. Gailly NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1 Cardiovasc. Res. 92 2011 237 246
6. M. Balteau, A. Van Steenbergen, A.D. Timmermans, C. Dessy, G. Behets-Wydemans, N. Tajeddine, D. Castanares-Zapatero, P. Gilon, J.L. Vanoverschelde, and S. Horman AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes Am. J. Physiol. Heart Circ. Physiol. 2014 Published online August 15, 2014
7. C. Batandier, B. Guigas, D. Detaille, M.Y. El-Mir, E. Fontaine, M. Rigoulet, and X.M. Leverve The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin J. Bioenerg. Biomembr. 38 2006 33 42
8. B. Batchuluun, T. Inoguchi, N. Sonoda, S. Sasaki, T. Inoue, Y. Fujimura, D. Miura, and R. Takayanagi Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells Atherosclerosis 232 2014 156 164
9. M.L. Becker, L.E. Visser, R.H. van Schaik, A. Hofman, A.G. Uitterlinden, and B.H. Stricker Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study Diabetes 58 2009 745 749
10. I. Ben Sahra, K. Laurent, S. Giuliano, F. Larbret, G. Ponzio, P. Gounon, Y. Le Marchand-Brustel, S. Giorgetti-Peraldi, M. Cormont, and C. Bertolotto Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells Cancer Res. 70 2010 2465 2475
11. L. Bertrand, A. Ginion, C. Beauloye, A.D. Hebert, B. Guigas, L. Hue, and J.L. Vanoverschelde AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B Am. J. Physiol. Heart Circ. Physiol. 291 2006 H239 H250
12. G.S. Bhamra, D.J. Hausenloy, S.M. Davidson, R.D. Carr, M. Paiva, A.M. Wynne, M.M. Mocanu, and D.M. Yellon Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening Basic Res. Cardiol. 103 2008 274 284
13. M.P. Bhatt, Y.C. Lim, Y.M. Kim, and K.S. Ha C-peptide activates AMPKα and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes Diabetes 62 2013 3851 3862
14. K. Birsoy, R. Possemato, F.K. Lorbeer, E.C. Bayraktar, P. Thiru, B. Yucel, T. Wang, W.W. Chen, C.B. Clish, and D.M. Sabatini Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides Nature 508 2014 108 112
15. R. Boussageon, I. Supper, T. Bejan-Angoulvant, N. Kellou, M. Cucherat, J.P. Boissel, B. Kassai, A. Moreau, F. Gueyffier, and C. Cornu Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials PLoS Med. 9 2012 e1001204
16. H.R. Bridges, A.J. Jones, M.N. Pollak, and J. Hirst Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria Biochem. J. 462 2014 475 487
17. B. Brunmair, K. Staniek, F. Gras, N. Scharf, A. Althaym, R. Clara, M. Roden, E. Gnaiger, H. Nohl, W. Waldhäusl, and C. Fürnsinn Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53 2004 1052 1059
18. H. Bugger, and E.D. Abel Molecular mechanisms of diabetic cardiomyopathy Diabetologia 57 2014 660 671
19. M. Buzzai, R.G. Jones, R.K. Amaravadi, J.J. Lum, R.J. DeBerardinis, F. Zhao, B. Viollet, and C.B. Thompson Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth Cancer Res. 67 2007 6745 6752
20. F. Cabreiro, C. Au, K.Y. Leung, N. Vergara-Irigaray, H.M. Cochemé, T. Noori, D. Weinkove, E. Schuster, N.D. Greene, and D. Gems Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism Cell 153 2013 228 239
21. J. Cao, S. Meng, E. Chang, K. Beckwith-Fickas, L. Xiong, R.N. Cole, S. Radovick, F.E. Wondisford, and L. He Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK) J. Biol. Chem. 289 2014 20435 20446
22. P.W. Caton, N.K. Nayuni, J. Kieswich, N.Q. Khan, M.M. Yaqoob, and R. Corder Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5 J. Endocrinol. 205 2010 97 106
23. W.S. Cheang, X.Y. Tian, W.T. Wong, C.W. Lau, S.S. Lee, Z.Y. Chen, X. Yao, N. Wang, and Y. Huang Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5′ adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway Arterioscler. Thromb. Vasc. Biol. 34 2014 830 836
24. J. De Jager, A. Kooy, P. Lehert, D. Bets, M.G. Wulffelé, T. Teerlink, P.G. Scheffer, C.G. Schalkwijk, A.J. Donker, and C.D. Stehouwer Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial J. Intern. Med. 257 2005 100 109
25. D. Detaille, B. Guigas, C. Chauvin, C. Batandier, E. Fontaine, N. Wiernsperger, and X. Leverve Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process Diabetes 54 2005 2179 2187
26. Z. Drahota, E. Palenickova, R. Endlicher, M. Milerova, J. Brejchova, M. Vosahlikova, P. Svoboda, L. Kazdova, M. Kalous, Z. Cervinkova, and M. Cahova Biguanides inhibit complex I, II and IV of rat liver mitochondria and modify their functional properties Physiol. Res. 63 2014 1 11
27. J.A. Dykens, J. Jamieson, L. Marroquin, S. Nadanaciva, P.A. Billis, and Y. Will Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro Toxicol. Appl. Pharmacol. 233 2008 203 210
28. M.Y. El-Mir, V. Nogueira, E. Fontaine, N. Avéret, M. Rigoulet, and X. Leverve Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I J. Biol. Chem. 275 2000 223 228
29. M.Y. El-Mir, D. Detaille, G. R-Villanueva, M. Delgado-Esteban, B. Guigas, S. Attia, E. Fontaine, A. Almeida, and X. Leverve Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons J. Mol. Neurosci. 34 2008 77 87
30. D.T. Eurich, D.L. Weir, S.R. Majumdar, R.T. Tsuyuki, J.A. Johnson, L. Tjosvold, S.E. Vanderloo, and F.A. McAlister Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients Circ. Heart Fail. 6 2013 395 402
31. J.M. Evans, L.A. Donnelly, A.M. Emslie-Smith, D.R. Alessi, and A.D. Morris Metformin and reduced risk of cancer in diabetic patients BMJ 330 2005 1304 1305
32. B. Faubert, G. Boily, S. Izreig, T. Griss, B. Samborska, Z. Dong, F. Dupuy, C. Chambers, B.J. Fuerth, and B. Viollet AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo Cell Metab. 17 2013 113 124
33. M. Foretz, S. Hébrard, J. Leclerc, E. Zarrinpashneh, M. Soty, G. Mithieux, K. Sakamoto, F. Andreelli, and B. Viollet Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state J. Clin. Invest. 120 2010 2355 2369
34. M.D. Fullerton, S. Galic, K. Marcinko, S. Sikkema, T. Pulinilkunnil, Z.P. Chen, H.M. O'Neill, R.J. Ford, R. Palanivel, and M. O'Brien Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin Nat. Med. 19 2013 1649 1654
35. S. Gandini, M. Puntoni, B.M. Heckman-Stoddard, B.K. Dunn, L. Ford, A. DeCensi, and E. Szabo Metformin and cancer risk and mortality: A systematic review and meta-analysis taking into account biases and confounders Cancer Prev. Res. (Phila). 7 2014 867 885
36. J.J. Geerling, M.R. Boon, G.C. van der Zon, S.A. van den Berg, A.M. van den Hoek, M. Lombès, H.M. Princen, L.M. Havekes, P.C. Rensen, and B. Guigas Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice Diabetes 63 2014 880 891
37. A. Ginion, J. Auquier, C.R. Benton, C. Mouton, J.L. Vanoverschelde, L. Hue, S. Horman, C. Beauloye, and L. Bertrand Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake Am. J. Physiol. Heart Circ. Physiol. 301 2011 H469 H477
38. L. Gong, S. Goswami, K.M. Giacomini, R.B. Altman, and T.E. Klein Metformin pathways: pharmacokinetics and pharmacodynamics Pharmacogenet. Genomics 22 2012 820 827
39. E. Gontier, E. Fourme, M. Wartski, C. Blondet, G. Bonardel, E. Le Stanc, M. Mantzarides, H. Foehrenbach, A.P. Pecking, and J.L. Alberini High and typical 18F-FDG bowel uptake in patients treated with metformin Eur. J. Nucl. Med. Mol. Imaging 35 2008 95 99
40. A.R. Grassian, S.J. Parker, S.M. Davidson, A.S. Divakaruni, C.R. Green, X. Zhang, K.L. Slocum, M. Pu, F. Lin, and C. Vickers IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism Cancer Res. 74 2014 3317 3331
41. S.M. Grundy, I.J. Benjamin, G.L. Burke, A. Chait, R.H. Eckel, B.V. Howard, W. Mitch, S.C. Smith Jr.; and J.R. Sowers Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association Circulation 100 1999 1134 1146
42. B. Guigas, D. Detaille, C. Chauvin, C. Batandier, F. De Oliveira, E. Fontaine, and X. Leverve Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study Biochem. J. 382 2004 877 884
43. S. Gundewar, J.W. Calvert, S. Jha, I. Toedt-Pingel, S.Y. Ji, D. Nunez, A. Ramachandran, M. Anaya-Cisneros, R. Tian, and D.J. Lefer Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure Circ. Res. 104 2009 403 411
44. R. Haq, J. Shoag, P. Andreu-Perez, S. Yokoyama, H. Edelman, G.C. Rowe, D.T. Frederick, A.D. Hurley, A. Nellore, and A.L. Kung Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF Cancer Cell 23 2013 302 315
45. S.A. Hawley, F.A. Ross, C. Chevtzoff, K.A. Green, A. Evans, S. Fogarty, M.C. Towler, L.J. Brown, O.A. Ogunbayo, A.M. Evans, and D.G. Hardie Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation Cell Metab. 11 2010 554 565
46. L. He, A. Sabet, S. Djedjos, R. Miller, X. Sun, M.A. Hussain, S. Radovick, and F.E. Wondisford Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein Cell 137 2009 635 646
47. C. He, H. Zhu, H. Li, M.H. Zou, and Z. Xie Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes Diabetes 62 2013 1270 1281
48. S.A. Hinke, G.A. Martens, Y. Cai, J. Finsi, H. Heimberg, D. Pipeleers, and M. Van de Casteele Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer Br. J. Pharmacol. 150 2007 1031 1043
49. A. Hirsch, D. Hahn, P. Kempná, G. Hofer, J.M. Nuoffer, P.E. Mullis, and C.E. Flück Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain Endocrinology 153 2012 4354 4366
50. G. Hollunger Guanidines and oxidative phosphorylations Acta Pharmacol. Toxicol. (Copenh.) 11 Suppl 1 1955 1 84
51. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N. Engl. J. Med. 359 2008 1577 1589
52. J. Hong, Y. Zhang, S. Lai, A. Lv, Q. Su, Y. Dong, Z. Zhou, W. Tang, J. Zhao, L. Cui SPREAD-DIMCAD Investigators Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease Diabetes Care 36 2013 1304 1311
53. S. Horman, C. Beauloye, J.L. Vanoverschelde, and L. Bertrand AMP-activated protein kinase in the control of cardiac metabolism and remodeling Curr. Heart Fail. Rep. 9 2012 164 173
54. K. Hosono, H. Endo, H. Takahashi, M. Sugiyama, E. Sakai, T. Uchiyama, K. Suzuki, H. Iida, Y. Sakamoto, and K. Yoneda Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial Cancer Prev. Res. (Phila.) 3 2010 1077 1083
55. X. Huang, S. Wullschleger, N. Shpiro, V.A. McGuire, K. Sakamoto, Y.L. Woods, W. McBurnie, S. Fleming, and D.R. Alessi Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice Biochem. J. 412 2008 211 221
56. K.A. Jablonski, J.B. McAteer, P.I. de Bakker, P.W. Franks, T.I. Pollin, R.L. Hanson, R. Saxena, S. Fowler, A.R. Shuldiner, W.C. Knowler Diabetes Prevention Program Research Group Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program Diabetes 59 2010 2672 2681
57. A. Janzer, N.J. German, K.N. Gonzalez-Herrera, J.M. Asara, M.C. Haigis, and K. Struhl Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells Proc. Natl. Acad. Sci. USA 111 2014 10574 10579
58. S.M. Jeon, N.S. Chandel, and N. Hay AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress Nature 485 2012 661 665
59. K.H. Kim, Y.T. Jeong, S.H. Kim, H.S. Jung, K.S. Park, H.Y. Lee, and M.S. Lee Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation Biochem. Biophys. Res. Commun. 440 2013 76 81
60. D. Kukidome, T. Nishikawa, K. Sonoda, K. Imoto, K. Fujisawa, M. Yano, H. Motoshima, T. Taguchi, T. Matsumura, and E. Araki Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells Diabetes 55 2006 120 127
61. C. Lamanna, M. Monami, N. Marchionni, and E. Mannucci Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials Diabetes Obes. Metab. 13 2011 221 228
62. J.M. Lee, W.Y. Seo, K.H. Song, D. Chanda, Y.D. Kim, D.K. Kim, M.W. Lee, D. Ryu, Y.H. Kim, and J.R. Noh AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner J. Biol. Chem. 285 2010 32182 32191
63. R.J. Legtenberg, R.J. Houston, B. Oeseburg, and P. Smits Metformin improves cardiac functional recovery after ischemia in rats Horm. Metab. Res. 34 2002 182 185
64. C.P. Lexis, I.C. van der Horst, E. Lipsic, W.G. Wieringa, R.A. de Boer, A.F. van den Heuvel, H.W. van der Werf, R.A. Schurer, G. Pundziute, E.S. Tan GIPS-III Investigators Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial JAMA 311 2014 1526 1535
65. H.Z. Lin, S.Q. Yang, C. Chuckaree, F. Kuhajda, G. Ronnet, and A.M. Diehl Metformin reverses fatty liver disease in obese, leptin-deficient mice Nat. Med. 6 2000 998 1003
66. L. Logie, J. Harthill, K. Patel, S. Bacon, D.L. Hamilton, K. Macrae, G. McDougall, H.H. Wang, L. Xue, and H. Jiang Cellular responses to the metal-binding properties of metformin Diabetes 61 2012 1423 1433
67. A.K. Madiraju, D.M. Erion, Y. Rahimi, X.M. Zhang, D.T. Braddock, R.A. Albright, B.J. Prigaro, J.L. Wood, S. Bhanot, and M.J. MacDonald Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase Nature 510 2014 542 546
68. A. Maida, B.J. Lamont, X. Cao, and D.J. Drucker Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice Diabetologia 54 2011 339 349
69. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, M. Zoli, and N. Melchionda Metformin in non-alcoholic steatohepatitis Lancet 358 2001 893 894
70. D. Margel, D.R. Urbach, L.L. Lipscombe, C.M. Bell, G. Kulkarni, P.C. Austin, and N. Fleshner Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes J. Clin. Oncol. 31 2013 3069 3075
71. F.A. Masoudi, S.E. Inzucchi, Y. Wang, E.P. Havranek, J.M. Foody, and H.M. Krumholz Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study Circulation 111 2005 583 590
72. R.M. Memmott, J.R. Mercado, C.R. Maier, S. Kawabata, S.D. Fox, and P.A. Dennis Metformin prevents tobacco carcinogen - induced lung tumorigenesis Cancer Prev. Res. (Phila.) 3 2010 1066 1076
73. R.A. Miller, Q. Chu, J. Xie, M. Foretz, B. Viollet, and M.J. Birnbaum Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP Nature 494 2013 256 260
74. O. Moiseeva, X. Deschênes-Simard, E. St-Germain, S. Igelmann, G. Huot, A.E. Cadar, V. Bourdeau, M.N. Pollak, and G. Ferbeyre Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation Aging Cell 12 2013 489 498
75. A.J. Mulherin, A.H. Oh, H. Kim, A. Grieco, L.M. Lauffer, and P.L. Brubaker Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell Endocrinology 152 2011 4610 4619
76. S. Muller, S. Denet, H. Candiloros, R. Barrois, N. Wiernsperger, M. Donner, and P. Drouin Action of metformin on erythrocyte membrane fluidity in vitro and in vivo Eur. J. Pharmacol. 337 1997 103 110
77. K. Narise, K. Okuda, Y. Enomoto, T. Hirayama, and H. Nagasawa Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment Drug Des. Devel. Ther. 8 2014 701 717
78. A. Natali, and E. Ferrannini Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review Diabetologia 49 2006 434 441
79. G. Noppe, C. Dufeys, P. Buchlin, N. Marquet, D. Castanares-Zapatero, M. Balteau, N. Hermida, C. Bouzin, H. Esfahani, and B. Viollet Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1 J. Mol. Cell. Cardiol. 74 2014 32 43
80. N. Ouslimani, J. Peynet, D. Bonnefont-Rousselot, P. Thérond, A. Legrand, and J.L. Beaudeux Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells Metabolism 54 2005 829 834
81. N. Ouslimani, M. Mahrouf, J. Peynet, D. Bonnefont-Rousselot, C. Cosson, A. Legrand, and J.L. Beaudeux Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1 Metabolism 56 2007 308 313
82. M.R. Owen, E. Doran, and A.P. Halestrap Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem. J. 348 2000 607 614
83. M. Paiva, N.P. Riksen, S.M. Davidson, D.J. Hausenloy, P. Monteiro, L. Gonçalves, L. Providência, G.A. Rongen, P. Smits, M.M. Mocanu, and D.M. Yellon Metformin prevents myocardial reperfusion injury by activating the adenosine receptor J. Cardiovasc. Pharmacol. 53 2009 373 378
84. E.L. Pearce, M.C. Walsh, P.J. Cejas, G.M. Harms, H. Shen, L.S. Wang, R.G. Jones, and Y. Choi Enhancing CD8 T-cell memory by modulating fatty acid metabolism Nature 460 2009 103 107
85. S. Piel, J.K. Ehinger, E. Elmér, and M.J. Hansson Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibition Acta Physiol. (Oxf.) 2014 10.1111/apha.12311 Published online May 6, 2014
86. M. Pollak The insulin and insulin-like growth factor receptor family in neoplasia: an update Nat. Rev. Cancer 12 2012 159 169
87. M.N. Pollak Investigating metformin for cancer prevention and treatment: the end of the beginning Cancer Discov. 2 2012 778 790
88. M. Pollak Potential applications for biguanides in oncology J. Clin. Invest. 123 2013 3693 3700
89. M. Pollak Targeting oxidative phosphorylation: why, when, and how Cancer Cell 23 2013 263 264
90. M. Pollak Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment Nat. Med. 20 2014 591 593
91. D. Preiss, S.M. Lloyd, I. Ford, J.J. McMurray, R.R. Holman, P. Welsh, M. Fisher, C.J. Packard, and N. Sattar Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial Lancet Diabetes Endocrinol. 2 2014 116 124
92. M.A. Preston, A.H. Riis, V. Ehrenstein, R.H. Breau, J.L. Batista, A.F. Olumi, L.A. Mucci, H.O. Adami, and H.T. Sørensen Metformin Use and Prostate Cancer Risk Eur. Urol. 2014
93. V.T. Samuel, S.A. Beddow, T. Iwasaki, X.M. Zhang, X. Chu, C.D. Still, G.S. Gerhard, and G.I. Shulman Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes Proc. Natl. Acad. Sci. USA 106 2009 12121 12126
94. H. Sasaki, H. Asanuma, M. Fujita, H. Takahama, M. Wakeno, S. Ito, A. Ogai, M. Asakura, J. Kim, and T. Minamino Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase Circulation 119 2009 2568 2577
95. S. Scotland, E. Saland, N. Skuli, F. de Toni, H. Boutzen, E. Micklow, I. Sénégas, R. Peyraud, L. Peyriga, and F. Théodoro Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells Leukemia 27 2013 2129 2138
96. D.B. Shackelford, E. Abt, L. Gerken, D.S. Vasquez, A. Seki, M. Leblanc, L. Wei, M.C. Fishbein, J. Czernin, P.S. Mischel, and R.J. Shaw LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin Cancer Cell 23 2013 143 158
97. R.J. Shaw, K.A. Lamia, D. Vasquez, S.H. Koo, N. Bardeesy, R.A. Depinho, M. Montminy, and L.C. Cantley The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin Science 310 2005 1642 1646
98. Y. Shu, S.A. Sheardown, C. Brown, R.P. Owen, S. Zhang, R.A. Castro, A.G. Ianculescu, L. Yue, J.C. Lo, and E.G. Burchard Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action J. Clin. Invest. 117 2007 1422 1431
99. X. Stephenne, M. Foretz, N. Taleux, G.C. van der Zon, E. Sokal, L. Hue, B. Viollet, and B. Guigas Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status Diabetologia 54 2011 3101 3110
100. S. Suissa, and L. Azoulay Metformin and cancer: mounting evidence against an association Diabetes Care 37 2014 1786 1788
101. A.D. Timmermans, M. Balteau, R. Gélinas, E. Renguet, A. Ginion, C. de Meester, K. Sakamoto, J.L. Balligand, F. Bontemps, and J.L. Vanoverschelde A-769662 potentiates the effect of other AMP-activated protein kinase activators on cardiac glucose uptake Am. J. Physiol. Heart Circ. Physiol. 306 2014 H1619 H1630
102. K.K. Tsilidis, D. Capothanassi, N.E. Allen, E.C. Rizos, D.S. Lopez, K. van Veldhoven, C. Sacerdote, D. Ashby, P. Vineis, I. Tzoulaki, and J.P. Ioannidis Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial Diabetes Care 37 2014 2522 2532
103. M. Tsuda, T. Terada, T. Mizuno, T. Katsura, J. Shimakura, and K. Inui Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin Mol. Pharmacol. 75 2009 1280 1286
104. G.T. Tucker, C. Casey, P.J. Phillips, H. Connor, J.D. Ward, and H.F. Woods Metformin kinetics in healthy subjects and in patients with diabetes mellitus Br. J. Clin. Pharmacol. 12 1981 235 246
105. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
106. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli Cellular and molecular mechanisms of metformin: an overview Clin. Sci. 122 2012 253 270
107. W.W. Wheaton, S.E. Weinberg, R.B. Hamanaka, S. Soberanes, L.B. Sullivan, E. Anso, A. Glasauer, E. Dufour, G.M. Mutlu, G.S. Budigner, and N.S. Chandel Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis Elife 3 2014 e02242
108. H.J. Whittington, A.R. Hall, C.P. McLaughlin, D.J. Hausenloy, D.M. Yellon, and M.M. Mocanu Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon Cardiovasc. Drugs Ther. 27 2013 5 16
109. C. Wilcock, and C.J. Bailey Accumulation of metformin by tissues of the normal and diabetic mouse Xenobiotica 24 1994 49 57
110. S.L. Woo, H. Xu, H. Li, Y. Zhao, X. Hu, J. Zhao, X. Guo, T. Guo, R. Botchlett, and T. Qi Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity PLoS ONE 9 2014 e91111
111. W. Wu, K. Merriman, A. Nabaah, N. Seval, D. Seval, H. Lin, M. Wang, M.H. Qazilbash, V. Baladandayuthapani, and D. Berry The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma Br. J. Cancer 111 2014 628 636
112. H. Xiao, X. Ma, W. Feng, Y. Fu, Z. Lu, M. Xu, Q. Shen, Y. Zhu, and Y. Zhang Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway Cardiovasc. Res. 87 2010 504 513
113. Z. Xie, K. Lau, B. Eby, P. Lozano, C. He, B. Pennington, H. Li, S. Rathi, Y. Dong, and R. Tian Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice Diabetes 60 2011 1770 1778
114. X. Xu, Z. Lu, J. Fassett, P. Zhang, X. Hu, X. Liu, D. Kwak, J. Li, G. Zhu, and Y. Tao Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2 Hypertension 63 2014 723 728
115. C.H. Yeh, T.P. Chen, Y.C. Wang, Y.M. Lin, and S.W. Fang AMP-activated protein kinase activation during cardioplegia-induced hypoxia/reoxygenation injury attenuates cardiomyocytic apoptosis via reduction of endoplasmic reticulum stress Mediators Inflamm. 2010 2010 130636
116. M. Yin, I.C. van der Horst, J.P. van Melle, C. Qian, W.H. van Gilst, H.H. Silljé, and R.A. de Boer Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure Am. J. Physiol. Heart Circ. Physiol. 301 2011 H459 H468
117. M. Zakikhani, R. Dowling, I.G. Fantus, N. Sonenberg, and M. Pollak Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells Cancer Res. 66 2006 10269 10273
118. M. Zang, A. Zuccollo, X. Hou, D. Nagata, K. Walsh, H. Herscovitz, P. Brecher, N.B. Ruderman, and R.A. Cohen AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells J. Biol. Chem. 279 2004 47898 47905
119. C.X. Zhang, S.N. Pan, R.S. Meng, C.Q. Peng, Z.J. Xiong, B.L. Chen, G.Q. Chen, F.J. Yao, Y.L. Chen, Y.D. Ma, and Y.G. Dong Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats Clin. Exp. Pharmacol. Physiol. 38 2011 55 62
120. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, and N. Fujii Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 2001 1167 1174
121. K. Zhou, L.A. Donnelly, C.H. Kimber, P.T. Donnan, A.S. Doney, G. Leese, A.T. Hattersley, M.I. McCarthy, A.D. Morris, C.N. Palmer, and E.R. Pearson Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study Diabetes 58 2009 1434 1439
122. K. Zhou, C. Bellenguez, C.C. Spencer, A.J. Bennett, R.L. Coleman, R. Tavendale, S.A. Hawley, L.A. Donnelly, C. Schofield, C.J. Groves GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group Wellcome Trust Case Control Consortium 2 MAGIC investigators Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes Nat. Genet. 43 2011 117 120